ACP4
Testicular acid phosphatase
Also known as: ACPT, PPAT_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9BZG2
- Gene
- ACP4
- Ensembl
- ENSG00000142513
- Chromosome
- 19
- Canonical length
- 426 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins
- Subcellular location
- Nuclear bodies,Plasma membrane,Microtubules
- Quaternary structure
- Homodimer
OverviewNCBI Gene
Acid phosphatases are enzymes capable of hydrolyzing orthophosphoric acid esters in an acid medium. This gene is up-regulated by androgens and is down-regulated by estrogens in the prostate cancer cell line. This gene exhibits a lower level of expression in testicular cancer tissues than in normal tissues. The protein encoded by this gene has structural similarity to prostatic and lysosomal acid phosphatases. Alternatively spliced transcript variants have been described, but their biological validity has not been determined. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
426 residues, UniProt reviewed canonical sequence.
>Q9BZG2|ACP4
1 MAGLGFWGHP AGPLLLLLLL VLPPRALPEG PLVFVALVFR HGDRAPLASY PMDPHKEVAS
61 TLWPRGLGQL TTEGVRQQLE LGRFLRSRYE AFLSPEYRRE EVYIRSTDFD RTLESAQANL
121 AGLFPEAAPG SPEARWRPIP VHTVPVAEDK LLRFPMRSCP RYHELLREAT EAAEYQEALE
181 GWTGFLSRLE NFTGLSLVGE PLRRAWKVLD TLMCQQAHGL PLPAWASPDV LRTLAQISAL
241 DIGAHVGPPR AAEKAQLTGG ILLNAILANF SRVQRLGLPL KMVMYSAHDS TLLALQGALG
301 LYDGHTPPYA ACLGFEFRKH LGNPAKDGGN VTVSLFYRND SAHLPLPLSL PGCPAPCPLG
361 RFYQLTAPAR PPAHGVSCHG PYEAAIPPAP VVPLLAGAVA VLVALSLGLG LLAWRPGCLR
421 ALGGPVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ACP4 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.33
- Highest tissue expression
- 3.5 nTPM
Expression across tissuesHPA
Tissue
- testis: 3.5 nTPM
- skin: 1.1 nTPM
- bone marrow: 0.5 nTPM
- hippocampal formation: 0.3 nTPM
- amygdala: 0.2 nTPM
- pancreas: 0.2 nTPM
Single-cell type
- late spermatids: 567 nCPM
- early spermatids: 76 nCPM
- epicardial cells: 11 nCPM
- late primary spermatocytes: 6.4 nCPM
- oocytes: 4.6 nCPM
- hematopoietic stem cells: 1.5 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- cerebellum: 4.8 nTPM
- cerebral cortex: 3.6 nTPM
- amygdala: 3.1 nTPM
- hippocampal formation: 3.1 nTPM
- basal ganglia: 3 nTPM
- white matter: 2.5 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about ACP4.
Disease | AllUniProt
Conditions ACP4 is implicated in, by any mechanism.
- Amelogenesis imperfecta 1J (AI1J) MIM:617297
Disease | GeneticClinVar
13 pathogenic / likely-pathogenic of 134 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Amelogenesis imperfecta, type 1J
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.51
- gnomAD pLI
- 0
- DepMap mean gene effect
- 0.05
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- negative regulation of neuron projection development
- negative regulation of protein processing
- odontogenesis
- regulation of neuronal synaptic plasticity
- negative regulation of ERBB4 signaling pathway
- peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ACP4 as an antibody target. Whether an autoantibody or antibody against ACP4 could matter depends on whether native ACP4 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ACP4 is annotated at the cell surface, where native ACP4 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label ACP4 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...